BIOPHYSICAL JOURNAL, published by CELL PRESS, is a leading interdisciplinary platform dedicated to advancing the field of biophysics. With an ISSN of 0006-3495 and an E-ISSN of 1542-0086, this esteemed journal has garnered a prestigious position within the academic community, reflected in its ranking as Q1 in Biophysics for the year 2023. Its Scopus rank of #44/152 in the category of Biochemistry, Genetics, and Molecular Biology showcases its significant influence, with a notable percentile of 71st. Since its inception in 1960, the journal has published cutting-edge research that explores the quantitative and qualitative aspects of biological phenomena, making it essential for researchers, professionals, and students in the field. While the journal operates under a subscription model, its rigorous peer-review process ensures the highest quality of published work, contributing to groundbreaking discoveries and innovations that shape the future of biophysics. For more information or to explore the latest research, please visit the journal’s platform.

COMPUTATIONAL BIOLOGY AND CHEMISTRY is a distinguished academic journal published by Elsevier Science Ltd, focusing on the dynamic intersection of computational biology, biochemistry, and chemistry. With an ISSN of 1476-9271 and an E-ISSN of 1476-928X, this journal is committed to disseminating high-quality research that employs computational techniques to solve complex biological and chemical problems. As of 2023, the journal holds a substantial impact factor reflecting its significance and rigorous peer-review process, categorized in the Q2 quartile for both Computational Mathematics and Organic Chemistry, alongside Q3 classifications in Biochemistry and Structural Biology. With a continuous publication history spanning from 2003 to 2024, it serves as a critical resource for researchers, professionals, and students alike. The journal offers various open access options, ensuring that vital research findings are accessible to a global audience, further enhancing collaboration across disciplines. Engage with cutting-edge studies and contribute to the evolving landscape of computational methodologies in the life sciences through this esteemed publication.

CURRENT OPINION IN STRUCTURAL BIOLOGY is a premier journal published by CURRENT BIOLOGY LTD that serves as a critical platform for disseminating comprehensive reviews and the latest insights into the field of structural biology. With an impressive impact factor and ranked in the top quartile (Q1) in both Molecular Biology and Structural Biology categories, this journal exemplifies excellence in its scope and academic rigor. Researchers and professionals benefit from its insightful articles that cover cutting-edge developments, methodological advancements, and the implications of structural biology in various biological contexts. As part of the esteemed Current Biology series, the journal is committed to enriching the scientific community's understanding of biomolecular structures and their functions. Based in the United Kingdom and indexed in Scopus with high rankings in multiple relevant fields, CURRENT OPINION IN STRUCTURAL BIOLOGY remains an essential resource for scholars at every stage of their academic journey, from students to seasoned researchers, ensuring the ongoing progress of knowledge in this dynamic field.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

The International Journal of Biological Macromolecules, published by Elsevier, is a premier journal in the field of biological sciences, distinguished for its rigorous peer-review process and commitment to advancing research in biochemistry, molecular biology, and structural biology. With a Q1 categorization in multiple disciplines, including biochemistry and molecular biology, and an impressive Scopus ranking positioning it among the top echelons of its field, this journal is essential for researchers and professionals dedicated to exploring the complex interactions and applications of macromolecules. The journal, which has been publishing significant findings since 1979, provides a vital platform for disseminating innovative research that addresses critical challenges in various sectors such as medicine, agriculture, and materials science. Though it does not currently offer open access options, its impact on the scientific community is reflected in its H-index and percentile rankings, placing it firmly within the top tiers of its classification. By fostering a deeper understanding of biological macromolecules, this journal continues to contribute significantly to scientific knowledge and technological advancement.

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

Computational and Structural Biotechnology Journal is a premier open-access journal published by Elsevier, focusing on the intersection of computer science and molecular biology. Since its inception in 2012, the journal has established itself as a leading platform for innovative research, featuring groundbreaking studies in biochemistry, biophysics, biotechnology, and genetics. With a remarkable Q1 ranking in multiple categories, including Biochemistry and Genetics, it stands out for its high impact, evidenced by its strong Scopus ranking percentile scores. As a vital resource for researchers, professionals, and students, the journal aims to foster the dissemination of essential findings that leverage computational techniques to explore complex biological systems. In a rapidly evolving scientific landscape, Computational and Structural Biotechnology Journal serves as an indispensable resource for those looking to contribute and stay abreast of major advancements in the field.

The Journal of Structural Biology-X, published by Elsevier, is a leading open-access journal dedicated to advancing the field of structural biology. Launched in 2019, it has quickly established itself as a vital resource for researchers, professionals, and students, boasting a prestigious Q1 ranking in Structural Biology for 2023 and achieving an impressive Scopus rank of #19 out of 49 in the biochemistry, genetics, and molecular biology category. With an E-ISSN of 2590-1524, this journal emphasizes accessibility and collaboration by providing open access to its comprehensive collection of research articles, reviews, and cutting-edge methodologies. The scope of the journal encompasses significant themes within structural biology, including protein structure, molecular interactions, and imaging techniques, facilitating interdisciplinary dialogue and innovation. Join the global community of scientists and contribute to the body of knowledge that propels our understanding of molecular architecture through the Journal of Structural Biology-X.

AIMS Biophysics, published by the American Institute of Mathematical Sciences (AIMS), is an esteemed open-access journal dedicated to advancing the fields of biophysics, biochemistry, molecular biology, and structural biology. Launched in 2014, this journal provides a platform for researchers and professionals to disseminate high-quality research findings that contribute to the understanding of complex biological systems at the molecular level. With an ISSN of 2377-9098, AIMS Biophysics is indexed in Scopus, where it ranks in the fourth quartile across several categories, reflecting its commitment to addressing important issues within the scientific community. The journal aims to foster interdisciplinary collaboration and innovation through the publication of original research, reviews, and methodologies that advance the field. The open-access model ensures that cutting-edge research is freely available, promoting global access to scientific knowledge and enhancing visibility for authors. Nestled in the vibrant scientific landscape of the United States, AIMS Biophysics is poised to impact the evolving discourse in biophysics and related areas as it continues through its convergence period from 2014 to 2024.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.